MCL coexpression mm9:3126
From FANTOM5_SSTAR
Phase1 CAGE Peaks
Short description | |
---|---|
Mm9::chr17:88071863..88071920,+ | p1@Msh2 |
Mm9::chr17:88374384..88374425,+ | p1@Msh6 |
Mm9::chr17:88374426..88374447,+ | p2@Msh6 |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0032301 | MutSalpha complex | 1.10459508071702e-06 |
GO:0032137 | guanine/thymine mispair binding | 1.10459508071702e-06 |
GO:0032134 | mispaired DNA binding | 1.10459508071702e-06 |
GO:0045910 | negative regulation of DNA recombination | 1.32551409686043e-06 |
GO:0032300 | mismatch repair complex | 1.32551409686043e-06 |
GO:0000018 | regulation of DNA recombination | 1.84099180119504e-06 |
GO:0008340 | determination of adult life span | 3.31378524215107e-06 |
GO:0002566 | somatic diversification of immune receptors via somatic mutation | 3.43651802889741e-06 |
GO:0016446 | somatic hypermutation of immunoglobulin genes | 3.43651802889741e-06 |
GO:0030983 | mismatched DNA binding | 3.97654229058129e-06 |
GO:0010259 | multicellular organismal aging | 4.51879805747873e-06 |
GO:0006298 | mismatch repair | 5.06272745328636e-06 |
GO:0045005 | maintenance of fidelity during DNA-dependent DNA replication | 5.60794425594797e-06 |
GO:0051053 | negative regulation of DNA metabolic process | 7.17986802466065e-06 |
GO:0002208 | somatic diversification of immunoglobulins during immune response | 1.15982483475287e-05 |
GO:0051052 | regulation of DNA metabolic process | 1.15982483475287e-05 |
GO:0002204 | somatic recombination of immunoglobulin genes during immune response | 1.15982483475287e-05 |
GO:0003684 | damaged DNA binding | 1.15982483475287e-05 |
GO:0045190 | isotype switching | 1.15982483475287e-05 |
GO:0003690 | double-stranded DNA binding | 1.15982483475287e-05 |
GO:0002381 | immunoglobulin production during immune response | 1.21505458878873e-05 |
GO:0009411 | response to UV | 1.50626601915958e-05 |
GO:0016447 | somatic recombination of immunoglobulin gene segments | 1.68570814492033e-05 |
GO:0007568 | aging | 1.72486770296581e-05 |
GO:0016444 | somatic cell DNA recombination | 1.72486770296581e-05 |
GO:0002562 | somatic diversification of immune receptors via germline recombination within a single locus | 1.72486770296581e-05 |
GO:0016445 | somatic diversification of immunoglobulins | 1.77962540782187e-05 |
GO:0002200 | somatic diversification of immune receptors | 1.95671128584158e-05 |
GO:0042770 | DNA damage response, signal transduction | 2.266324389747e-05 |
GO:0002377 | immunoglobulin production | 2.72834984937105e-05 |
GO:0002440 | production of molecular mediator of immune response | 2.77930375148154e-05 |
GO:0006261 | DNA-dependent DNA replication | 3.57267471419412e-05 |
GO:0043566 | structure-specific DNA binding | 3.77570682136001e-05 |
GO:0016064 | immunoglobulin mediated immune response | 7.84262507309087e-05 |
GO:0019724 | B cell mediated immunity | 7.84262507309087e-05 |
GO:0009416 | response to light stimulus | 8.06354408923426e-05 |
GO:0006310 | DNA recombination | 8.06354408923428e-05 |
GO:0042113 | B cell activation | 0.000103773801004205 |
GO:0002250 | adaptive immune response | 0.000108139858402197 |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 0.000108139858402197 |
GO:0002449 | lymphocyte mediated immunity | 0.000112510898935891 |
GO:0009314 | response to radiation | 0.000112510898935891 |
GO:0002443 | leukocyte mediated immunity | 0.000124613738059495 |
GO:0006260 | DNA replication | 0.000222023611224122 |
GO:0002252 | immune effector process | 0.000222023611224122 |
GO:0009628 | response to abiotic stimulus | 0.000336853473745617 |
GO:0006281 | DNA repair | 0.000408723681888293 |
GO:0046649 | lymphocyte activation | 0.000408838254250388 |
GO:0032302 | MutSbeta complex | 0.000411450396188717 |
GO:0045321 | leukocyte activation | 0.000466470502586799 |
GO:0001775 | cell activation | 0.000526523655141781 |
GO:0006974 | response to DNA damage stimulus | 0.000564299390754764 |
GO:0002520 | immune system development | 0.000636676331246617 |
GO:0009719 | response to endogenous stimulus | 0.000636676331246617 |
GO:0045934 | negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 0.000650405667073105 |
GO:0004422 | hypoxanthine phosphoribosyltransferase activity | 0.000720018468418099 |
GO:0031324 | negative regulation of cellular metabolic process | 0.000823330291216552 |
GO:0009892 | negative regulation of metabolic process | 0.00100799824090832 |
GO:0031573 | intra-S DNA damage checkpoint | 0.00100799824090832 |
GO:0019237 | centromeric DNA binding | 0.00100799824090832 |
GO:0042981 | regulation of apoptosis | 0.00125630487721288 |
GO:0043067 | regulation of programmed cell death | 0.00125996328253913 |
GO:0006301 | postreplication repair | 0.00125996328253913 |
GO:0010224 | response to UV-B | 0.00125996328253913 |
GO:0006955 | immune response | 0.00192923478666894 |
GO:0006915 | apoptosis | 0.00302761143479985 |
GO:0006259 | DNA metabolic process | 0.00303708417443146 |
GO:0012501 | programmed cell death | 0.00303708417443146 |
GO:0010165 | response to X-ray | 0.00316136667868932 |
GO:0008219 | cell death | 0.00316136667868932 |
GO:0016265 | death | 0.00316136667868932 |
GO:0002376 | immune system process | 0.00394897343835839 |
GO:0006950 | response to stress | 0.00410388848509244 |
GO:0008630 | DNA damage response, signal transduction resulting in induction of apoptosis | 0.00456783940125631 |
GO:0000077 | DNA damage checkpoint | 0.00456783940125631 |
GO:0048523 | negative regulation of cellular process | 0.00485662842114258 |
GO:0031570 | DNA integrity checkpoint | 0.00523391578181307 |
GO:0010212 | response to ionizing radiation | 0.00539547157395146 |
GO:0048519 | negative regulation of biological process | 0.00539547157395146 |
GO:0043524 | negative regulation of neuron apoptosis | 0.00579281417436577 |
GO:0044428 | nuclear part | 0.00638815623589258 |
GO:0000075 | cell cycle checkpoint | 0.00638815623589258 |
GO:0008629 | induction of apoptosis by intracellular signals | 0.0072813443799675 |
GO:0000790 | nuclear chromatin | 0.00743427994164438 |
GO:0016763 | transferase activity, transferring pentosyl groups | 0.0078203772286416 |
GO:0048468 | cell development | 0.00786280319950723 |
GO:0043523 | regulation of neuron apoptosis | 0.00787191588747264 |
GO:0030183 | B cell differentiation | 0.00801113858398435 |
GO:0051402 | neuron apoptosis | 0.00859937199282748 |
GO:0005524 | ATP binding | 0.00930677812585996 |
GO:0032559 | adenyl ribonucleotide binding | 0.00943009814178596 |
GO:0007050 | cell cycle arrest | 0.00984950624419794 |
GO:0030554 | adenyl nucleotide binding | 0.0101680471426959 |
GO:0006119 | oxidative phosphorylation | 0.0109234700143371 |
GO:0006164 | purine nucleotide biosynthetic process | 0.0136196908178191 |
GO:0032553 | ribonucleotide binding | 0.0136196908178191 |
GO:0032555 | purine ribonucleotide binding | 0.0136196908178191 |
GO:0043234 | protein complex | 0.0136196908178191 |
GO:0044454 | nuclear chromosome part | 0.0136196908178191 |
GO:0017076 | purine nucleotide binding | 0.0144140821272926 |
GO:0048731 | system development | 0.0145733056803732 |
GO:0006163 | purine nucleotide metabolic process | 0.0145974080908556 |
GO:0048869 | cellular developmental process | 0.014926117176959 |
GO:0030154 | cell differentiation | 0.014926117176959 |
GO:0000228 | nuclear chromosome | 0.0149452030019608 |
GO:0000166 | nucleotide binding | 0.0172915378599145 |
GO:0030098 | lymphocyte differentiation | 0.0172915378599145 |
GO:0003677 | DNA binding | 0.017417163183156 |
GO:0003682 | chromatin binding | 0.0181611850926484 |
GO:0048856 | anatomical structure development | 0.0181611850926484 |
GO:0019219 | regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 0.0181611850926484 |
GO:0032991 | macromolecular complex | 0.0189921612564465 |
GO:0045786 | negative regulation of progression through cell cycle | 0.0206311186083919 |
GO:0001701 | in utero embryonic development | 0.0208278894505394 |
GO:0031323 | regulation of cellular metabolic process | 0.0208278894505394 |
GO:0009165 | nucleotide biosynthetic process | 0.0211335987252187 |
GO:0007275 | multicellular organismal development | 0.0214186646059709 |
GO:0002521 | leukocyte differentiation | 0.0214186646059709 |
GO:0019222 | regulation of metabolic process | 0.0214186646059709 |
GO:0006917 | induction of apoptosis | 0.0214186646059709 |
GO:0012502 | induction of programmed cell death | 0.0214186646059709 |
GO:0044446 | intracellular organelle part | 0.0236398165012331 |
GO:0044422 | organelle part | 0.0236398165012331 |
GO:0043066 | negative regulation of apoptosis | 0.0241275812678535 |
GO:0043069 | negative regulation of programmed cell death | 0.0242544955368895 |
GO:0043065 | positive regulation of apoptosis | 0.0259656376627664 |
GO:0043068 | positive regulation of programmed cell death | 0.0260758368641234 |
GO:0000074 | regulation of progression through cell cycle | 0.027900544291027 |
GO:0009117 | nucleotide metabolic process | 0.0281485248832004 |
GO:0000785 | chromatin | 0.0296989949745331 |
GO:0055086 | nucleobase, nucleoside and nucleotide metabolic process | 0.0296989949745331 |
GO:0003676 | nucleic acid binding | 0.0308758257953824 |
GO:0030097 | hemopoiesis | 0.0313512986094566 |
GO:0032502 | developmental process | 0.0323943610132257 |
GO:0043009 | chordate embryonic development | 0.0328055083993732 |
GO:0009792 | embryonic development ending in birth or egg hatching | 0.0330036116311129 |
GO:0048534 | hemopoietic or lymphoid organ development | 0.0336794882180467 |
GO:0016757 | transferase activity, transferring glycosyl groups | 0.0336794882180467 |
GO:0006139 | nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 0.0340527432305236 |
GO:0016887 | ATPase activity | 0.0373182871840627 |
GO:0050794 | regulation of cellular process | 0.0386077915932061 |
GO:0044427 | chromosomal part | 0.0422449277084787 |
GO:0006928 | cell motility | 0.0449610239423505 |
GO:0051674 | localization of cell | 0.0449610239423505 |
GO:0050789 | regulation of biological process | 0.0465663462567136 |
GO:0051726 | regulation of cell cycle | 0.0478692544526144 |
GO:0005694 | chromosome | 0.0482161388422169 |
Relative expression of the co-expression cluster over median <br>Analyst:
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
anterior region of body | 4.27e-09 | 43 |
hemopoietic organ | 4.28e-09 | 29 |
immune organ | 4.28e-09 | 29 |
primordium | 9.29e-08 | 134 |
craniocervical region | 2.36e-07 | 36 |
thymus | 5.46e-07 | 23 |
neck | 5.46e-07 | 23 |
respiratory system epithelium | 5.46e-07 | 23 |
hemolymphoid system gland | 5.46e-07 | 23 |
pharyngeal epithelium | 5.46e-07 | 23 |
thymic region | 5.46e-07 | 23 |
pharyngeal gland | 5.46e-07 | 23 |
entire pharyngeal arch endoderm | 5.46e-07 | 23 |
thymus primordium | 5.46e-07 | 23 |
early pharyngeal endoderm | 5.46e-07 | 23 |
gland of gut | 9.89e-07 | 24 |
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
MA0003.1 | 0.526413 |
MA0004.1 | 0.801718 |
MA0006.1 | 0.60285 |
MA0007.1 | 3.07498 |
MA0009.1 | 1.27673 |
MA0014.1 | 2.60474 |
MA0017.1 | 0.635031 |
MA0019.1 | 1.08369 |
MA0024.1 | 2.75393 |
MA0025.1 | 1.51835 |
MA0027.1 | 2.9431 |
MA0028.1 | 0.61552 |
MA0029.1 | 1.20789 |
MA0030.1 | 1.21482 |
MA0031.1 | 1.17722 |
MA0038.1 | 0.963265 |
MA0040.1 | 1.28983 |
MA0041.1 | 0.714279 |
MA0042.1 | 0.69885 |
MA0043.1 | 1.3775 |
MA0046.1 | 1.31428 |
MA0048.1 | 0.353763 |
MA0050.1 | 0.845669 |
MA0051.1 | 0.973068 |
MA0052.1 | 1.29825 |
MA0055.1 | 0.190475 |
MA0056.1 | 0 |
MA0057.1 | 0.337566 |
MA0058.1 | 0.690848 |
MA0059.1 | 0.705317 |
MA0060.1 | 3.20384 |
MA0061.1 | 0.5406 |
MA0063.1 | 0 |
MA0066.1 | 0.951196 |
MA0067.1 | 1.63197 |
MA0068.1 | 0.343188 |
MA0069.1 | 1.29861 |
MA0070.1 | 1.28847 |
MA0071.1 | 0.844726 |
MA0072.1 | 1.2796 |
MA0073.1 | 0.121346 |
MA0074.1 | 0.911576 |
MA0076.1 | 0.657929 |
MA0077.1 | 1.2569 |
MA0078.1 | 1.0091 |
MA0081.1 | 0.732313 |
MA0083.1 | 1.37668 |
MA0084.1 | 1.96428 |
MA0087.1 | 1.33189 |
MA0088.1 | 0.27999 |
MA0089.1 | 0 |
MA0090.1 | 0.762482 |
MA0091.1 | 0.816659 |
MA0092.1 | 0.762845 |
MA0093.1 | 0.62555 |
MA0095.1 | 0 |
MA0098.1 | 0 |
MA0100.1 | 0.89873 |
MA0101.1 | 0.71579 |
MA0103.1 | 0.647985 |
MA0105.1 | 1.04599 |
MA0106.1 | 1.01755 |
MA0107.1 | 0.640607 |
MA0108.2 | 1.10817 |
MA0109.1 | 0 |
MA0111.1 | 0.778753 |
MA0113.1 | 0.986839 |
MA0114.1 | 0.537669 |
MA0115.1 | 1.38041 |
MA0116.1 | 0.602598 |
MA0117.1 | 1.34691 |
MA0119.1 | 0.716476 |
MA0122.1 | 1.36752 |
MA0124.1 | 1.57762 |
MA0125.1 | 1.5017 |
MA0130.1 | 0 |
MA0131.1 | 1.07881 |
MA0132.1 | 0 |
MA0133.1 | 0 |
MA0135.1 | 1.4152 |
MA0136.1 | 0.933582 |
MA0139.1 | 0.462282 |
MA0140.1 | 0.898603 |
MA0141.1 | 0.671467 |
MA0142.1 | 1.16183 |
MA0143.1 | 1.00467 |
MA0144.1 | 0.541532 |
MA0145.1 | 0.292366 |
MA0146.1 | 1.44443 |
MA0147.1 | 0.556853 |
MA0148.1 | 0.820161 |
MA0149.1 | 0.722227 |
MA0062.2 | 1.06145 |
MA0035.2 | 0.903829 |
MA0039.2 | 3.91141 |
MA0138.2 | 1.07027 |
MA0002.2 | 0.466067 |
MA0137.2 | 0.668025 |
MA0104.2 | 0.48458 |
MA0047.2 | 0.962424 |
MA0112.2 | 0.29236 |
MA0065.2 | 0.292912 |
MA0150.1 | 0.784464 |
MA0151.1 | 0 |
MA0152.1 | 0.962542 |
MA0153.1 | 1.43238 |
MA0154.1 | 0.35067 |
MA0155.1 | 0.312898 |
MA0156.1 | 0.656895 |
MA0157.1 | 1.12772 |
MA0158.1 | 0 |
MA0159.1 | 0.569393 |
MA0160.1 | 0.823568 |
MA0161.1 | 0 |
MA0162.1 | 0.166722 |
MA0163.1 | 0.157796 |
MA0164.1 | 0.933981 |
MA0080.2 | 0.64167 |
MA0018.2 | 0.944669 |
MA0099.2 | 1.06348 |
MA0079.2 | 1.81944 |
MA0102.2 | 2.01714 |
MA0258.1 | 0.520639 |
MA0259.1 | 1.34197 |
MA0442.1 | 0 |